News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Marinomed Biotech AG: Binding Term Sheet for the intended issuance of a convertible bond to the European Investment Bank (EIB) signed
Marinomed Biotech AG signs Binding Term Sheet with European Investment Bank for convertible bond issuance. Convertible bond to be issued in December 2024 -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Marinomed Biotech AG: Publication of a report on the exclusion of subscription rights for a possible second cash capital in-crease of up to 154,053 shares
Marinomed Biotech AG plans a possible second cash capital increase and will publish a report on the exclusion of subscription rights. Negotiations ongoing with investors -
-
-
-
